ASMB News - Candlesense

Assembly Biosciences Announces Pricing of $175 Million in Equity Financings

SOUTH SAN FRANCISCO, Calif., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (“Assembly Bio”) (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting ser...

What is the market’s likely reaction to the issuance of both common shares and multiple layers of warrants (Class A, Class B, pre‑funded) on the stock’s price volatility? How might this financing affect the company's cash runway and burn rate? Are there any anti‑dilution or price‑adjustment provisions in the warrants that could affect future financing rounds?

Financing

17 days ago

Assembly Biosciences Reports Positive Interim Results from Phase 1b Clinical Study of Long-Acting Helicase-Primase Inhibitor Candidate ABI-5366 Showing Reductions in Viral Shedding Rate and Genital Lesion Rate in Recurrent Genital Herpes

– 94% reduction in HSV-2 shedding rate and 98% reduction in high viral load shedding rate, both statistically significant, observed in cohort evaluating 350 mg weekly oral dose compared to placebo ...

Are there plans to evaluate ABI‑5366 in other HSV‑1/HSV‑2 indications or broader antiviral indications? How might analysts adjust their coverage and consensus estimates for ASMB in response to these results? What regulatory pathway and timeline does the FDA anticipate for a new class of herpes therapeutics?

Clinical trials

17 days ago

Assembly Biosciences Reports Second Quarter 2025 Financial Results and Recent Updates

– On track for proof-of-concept Phase 1b data no later than this fall in participants with recurrent genital herpes for long-acting herpes simplex virus (HSV) helicase-primase inhibitor candidates,...

What is the likelihood of the company meeting its long‑term strategic milestones, and how does that shape the risk‑reward profile for a potential position? What macro‑economic or sector‑specific factors could amplify or dampen the stock’s reaction to the upcoming data release? How could partnerships or licensing deals with larger pharmaceutical companies affect future upside?

Earnings

18 days ago